Takeda Pharmaceutical Financial Statements
Takeda Pharmaceutical Financial Information
| Company Type | Public Headquarters |
|---|---|
| Fiscal Year-End | March |
© 2009 Morningstar, Inc. Financial Data provided by
Takeda Pharmaceutical Income Statement
| 2008 | 2007+ | 2006+ | |
|---|---|---|---|
| Revenue ($ mil.) | 13,845.6 | 11,073.0 | 10,177.7 |
| Gross Profit ($ mil.) | 11,039.5 | 8,700.4 | -- |
| Operating Income ($ mil.) | 5,812.7 | 5,307.8 | -- |
| Total Net Income ($ mil.) | 3,579.8 | 2,849.0 | 2,630.0 |
| Diluted EPS (Net Income) | 4.22 | 3.27 | -- |
- + Fiscal Year-End Change
Takeda Pharmaceutical Financial Ratios
| Company | Industry Median |
Market Median1 |
|
|---|---|---|---|
| Price/Sales Ratio | 2.32 | 2.58 | 7.01 |
| Price/Earnings Ratio | 8.57 | 16.39 | 25.51 |
| Price/Book Ratio | 1.38 | 2.81 | 6.74 |
| Price/Cash Flow Ratio | 10.92 | 9.89 | 43.48 |
1 Public companies trading on the New York Stock Exchange, the American Stock Exchange, and the NASDAQ National Market.
Detailed Takeda Pharmaceutical Financial Ratios
